BRTX

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 10/20/2017
Contact Info
  • 40 Marcus Drive
  • Suite One
  • Melville, NY 11747

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2017 10-Q
CIK 0001505497
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 8090 - Services-Misc Health & Allied Services, NEC
Incorporated In: DE, USA
Year of Inc. 2010
Employees 10 a/o Oct 19, 2017
Company Officers/Contacts
Mark Weinreb CEO
Mandy Clyde VP, Ops., Corporate Secretary
Francisco Silva VP, R&D, Chief Scientist
Company Directors
Mark Weinreb Chairman
Company Notes
  • Formerly=Stem Cell Assurance, Inc. until 9-2011
  • Formerly=Traxxec, Inc. until 8-2009
  • Formerly=Columbia River Resources, Inc. until 9-2008
Service Providers
Accounting/Auditing Firm
Marcum LLP
53 State Street, 38th Floor
Boston, MA, 02109
United States

Legal Counsel
Certilman Balin Adler & Hyman LLP
90 Merrick Avenue
9th Floor
East Meadow, NY, 11554
United States

Investor Relations Firm
Not Available
BRTX Security Details
Share Structure
Market Value1 $17,407,485 a/o Nov 17, 2017
Authorized Shares 30,000,000 a/o Oct 13, 2017
Outstanding Shares 5,439,839 a/o Oct 13, 2017
-Restricted 4,356,710 a/o Oct 13, 2017
-Unrestricted 1,083,129 a/o Oct 13, 2017
Held at DTC 1,035,275 a/o Oct 13, 2017
Float 922,730 a/o Apr 06, 2017
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
Island Stock Transfer
Shareholders
Shareholders of Record 288 a/o Mar 22, 2017
Short Selling Data
Short Interest 2,408 (-7.35%)
Oct 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security